Merck granted U.S. Patents for Foundational CRISPR-Cas9 Technology A leading science and technology company, Merck, announced that in the United States, two of its CRISPR-Cas9-assisted genome-editing patents have been allowed. In their work to advance and protect gene therapy development programs, these allowances provide Merck with the opportunity to support U.S. scientists and researchers. The […]

The post U.S. Patents for Foundational CRISPR-Cas9 Technology Granted To Merck & Co. appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/05/merck-granted-us-patents-for-foundational-crispr-cas9-technology/